Twitter announced today via a blog post that they are rolling out a new profile page format. For pharmaceutical marketers using Twitter, this means updating profile pages and if a product is mentioned, refiling the updated pages with the FDA under form 2253.
I mentioned this issue in a discussion of the Facebook adjustments to its brand pages just a few weeks ago.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.